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Resumo 
Neste trabalho desenvolveram-se novos materiais porosos para aplicações biomédicas 
utilizando tecnologia supercritica. Neste contexto, preparam-se dois tipos de materiais 
constituídos por quitosano e álcool polivinílico (PVA) em diferentes proporções: membranas 
e matrizes tri-dimensionais (3D). As membranas foram preparadas utilizando o método de 
inversão de fases e usando como não-solvente o dióxido de carbono supercrítico (scCO2). Os 
resultados obtidos na caracterização destes materiais revelaram que a presença de PVA nas 
membranas provoca a diminuição da porosidade e do ângulo de contacto e o aumento na 
interconectividade entre os poros e na capacidade de inchar. As propriedades mecânicas 
também se alteraram devido à presença de PVA nas membranas, aumentando a capacidade de 
elongamento e fazendo diminuir o valor da máxima tensão suportada. As matrizes 3D foram 
preparadas por liofilização e foram reticuladas com glutaraldeído, utilizando uma técnica 
assistida por CO2. A optimização deste processo de reticulação envolveu o estudo de 
diferentes concentrações de glutaraldeído e diferentes tempos de operação. A caracterização 
morfológica revelou que as diferentes concentrações da solução de polímero estudadas não 
afectaram a porosidade nem a interconectividade entre os poros das matrizes 3D. No entanto, 
a presença de PVA na composição destas matrizes e a temperatura utilizada no congelamento 
das soluções durante a formação das estruturas afectaram a sua morfologia. Estas matrizes 
porosas demostraram ainda a capacidade de inchar ou contrair quando colocadas em meios 
com diferentes valores de pH. As matrizes 3D reticuladas com 1% (v/v) de glutaraldeído 
durante 10 minutos apresentaram os melhores resultados. As membranas e as matrizes 3D 
foram também submetidas a testes de biodegradabilidade in vitro na presença de lisozima e a 
testes de citotoxicidade, mostrando ser potencialmente aplicáveis em engenharia de tecidos e 
em medicina regenerativa. 
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Abstract 
In this work new porous materials for biomedical applications were developed using 
supercritical fluids (SCF) technology. In this context, two types of porous structures 
constituted by blends of chitosan and poly (vinyl alcohol) (PVA) using different ratios were 
prepared: membranes and three dimensional (3D) scaffolds. Phase inversion method using 
supercritical carbon dioxide (scCO2) as non-solvent was used to prepare porous membranes. 
The characterization of these materials showed that the presence of PVA in the membranes 
composition causes a decrease in porosity values and contact angle and an increase on pores 
interconnectivity and swelling degree. The mechanical properties were also modified by the 
existence of PVA in the membranes composition, increasing the elongation capacity of these 
structures and decreasing the supported break stresses. The 3D-scaffolds were prepared using 
freeze-drying technique and were treated with glutaraldehyde using a CO2-assisted 
crosslinking process. The optimization of the crosslinking process comprised the study of 
different glutaraldehyde concentrations and operation time. Morphological characterization 
showed that the casting solution concentration was a parameter with no influence in the 3D-
scaffolds porosity neither on the pores interconnectivity. However, the PVA content in these 
matrices and the temperature used in the freeze-drying process determined their morphology. 
These highly porous structures were also submitted to dynamic swelling tests proving to be 
pH-sensitive with the capacity of swelling and deswelling when submitted to pH variations. 
The best response was obtained for scaffolds crosslinked with 1% (v/v) of glutaraldehyde 
during 10 minutes. Membranes and 3D-scaffolds were also tested for in vitro biodegradation 
using lysozyme and for cytotoxicity, proving to have potential applications in tissue 
engineering and regenerative medicine. 
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I. Introduction 
1. Supercritical Carbon Dioxide 
A Supercritical Fluid (SCF) is defined as a substance above its critical pressure (Pc) and 
temperature (Tc), where the density of the gas phase becomes equal to the density of the 
liquid phase and the interface between liquid and gas disappears1 (Figure 1.1). 
 
Figure 1.1 - Schematic representation of the change from liquid-gas equilibrium (T<Tc) to 
supercritical fluid (T>Tc) conditions as a substance is heated above its critical temperature and 
pressure (adapted from Cooper et al. 2). 
 
SCFs combine the properties of the two phases, presenting gas-like diffusivity and viscosity 
and liquid-like density as shown in Table 1.1. In addition, SCFs are highly compressible and 
their density, and therefore the solvent properties, can be tuned over a considerable range by 
varying the pressure.3 Figure 1.2 shows the rapid and continuous increasing in density for 
pure CO2 near the Pc and for a temperature above Tc.2  
Table 1.1 – Comparison of typical physical properties of gases, SCFs and liquids 
Properties Gas SCF Liquid 
Density (kg/m3) 1 100-800 1000 
Viscosity (cP) 0.01 0.05-0.1 0.5-1 
Diffusivity (m2/s) 1.10-5 1.10-7 1.10-9 
Increasing temperature and pressure 
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Figure 1.2 - Variation of density with pressure for pure CO2 at 35ºC. At this temperature (i.e., above 
Tc for CO2) there is a rapid but continuous increase in density near the critical pressure (Pc) (adapted 
from Cooper et al.2). 
 
The SCF technology involves high pressures and sometimes high temperatures (Table 1.2) 
and most of the times it will be easier to carry out the experiments under conventional 
conditions. Even so, there are several advantages when using these fluids for a variety of 
applications.4 
Table 1.2 – Critical conditions of a few substances 
Substance Tc (ºC) Pc (MPa) 
Carbon dioxide 31.1 7.38 
Water 374.2 22.1 
Methanol 239.9 8.08 
Ethane 31.9 4.87 
Propane 96.7 4.25 
Toluene 318.6 41.1 
Ammonia 132.5 11.3 
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Supercritical carbon dioxide (scCO2) is the most used SCF because it is an environmentally 
benign solvent, non-toxic, non-flammable, low cost and readily available in high purity from 
several sources. Besides, it has an accessible critical point with a Tc of 31.1 °C and a Pc of 
7.38 MPa (Figure 1.3). 
 
 
Figure 1.3 – Pressure-temperature phase diagram of pure CO2 and representation of critical point     
(Tc = 31.1 ºC and Pc = 7.38 MPa). 
 
In recent years, scCO2 has been widely used as a solvent, anti-solvent and plasticizer for 
synthesis, modification and purification of both synthetic and natural polymers. Therefore, the 
solvent properties of scCO2, i.e. the solubility of polymers in scCO2 and the solubility of 
scCO2 in polymers, are very important parameters.5 
ScCO2 is a very poor solvent for most polymers and pharmaceutical compounds and the 
polarity of polymers can be a reason for their limited solubility. In addition, CO2 has the 
potential to act as both a weak Lewis acid and Lewis base, and theoretical and experimental 
evidence indicates that CO2 can participate in hydrogen-bonding interactions. This suggests 
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that CO2 might solubilise dipolar and non-dipolar molecular systems through site-specific 
solute-solvent interactions.6 Beckman et al.7,8 have shown that by careful molecular design 
and choice of co-monomers to balance the solvent–solute and solute–solute interactions it is 
possible to prepare hydrocarbon based copolymers that are CO2-soluble. Furthermore, CO2 
solubility and diffusivity in polymers are influenced by both the molecular structure (the 
interaction between CO2 and molecular chains) and the morphology (crystalline or 
amorphous, related with free volume) of polymers.5 
 
2. Supercritical Fluids based methods for porous structures production 
Porous structures can be prepared using different methods by means of SCF technology like 
gas foaming9, supercritical fluid emulsion templating10 and phase inversion.11,12,13 
2.1. Gas foaming 
The formation of polymer foams occurs when a polymer, plasticized by saturation in the 
supercritical fluid is rapidly depressurized at a constant temperature. Pockets of gas nucleate 
and grow in the polymer as the pressure is released and as the supercritical fluid leaves the 
polymer, the glass transition temperature (Tg) increases. At the point where the Tg for the 
polymer is higher than the foaming temperature, the porous structure is set.5 
Mooney et al.14 prepared highly porous matrices from poly (lactic-co-glycolic acid) (PLGA) 
using gas foaming method. However, the scaffolds surface was formed by a non-porous film, 
making them unsuitable for cell ingress, and presenting a barrier for cell nutrients and for 
waste products of cell metabolism. This may happen due to the rapid diffusion of the CO2 
from the surface of the scaffold as the pressure is released. Furthermore, it was found that the 
scaffolds produced had a relatively closed pore-network. To overcome this issue, an 
additional porogen (sodium chloride crystals of a defined size range) was incorporated into 
compression moulded PLGA discs before gas foaming. Upon production of the polymer 
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foam, the porogen was leached out by incubation in water for 48 hours. This created a 
scaffold with an interconnected pore network open to the surface, which was shown to be 
accessible to cultured smooth muscle cells. Interconnectivity of the pores could be improved 
even further by partially fusing the salt porogen by exposure to 95% humidity.15 
The leaching of the porogen is a major disadvantage of the gas foaming/particulate leaching 
process since it results in the loss of the majority of any incorporated growth factor. This can 
be overcome somewhat by encapsulating the active factors in alginate beads which are then 
incorporated into the compressed polymer together with the porogen before processing. In 
addition to the issues surrounding salt leaching, the gas foaming process suffers from 
relatively long manufacturing time.16 
Under supercritical conditions, CO2 foams polymers to create porous scaffolds suitable for 
tissue engineering applications. Since increasing pressure, increases the rate of gas diffusion 
into polymer systems, equilibration time is reduced compared to subcritical pressures.17 Gas 
saturation equilibration times as low as 10 minutes have been reported.18,19 The effectiveness 
of this technique in foaming PLGA and use of the scaffolds for tissue engineering has been 
demonstrated both in vitro and in vivo.20,21,22 
Barry et al.23 used scCO2 to foam the non-degradable polymer poly(ethylmethacrylate)/ 
tetrahydrofurfuryl methacrylate (PEMA/THFMA), which has been shown to be an excellent 
scaffold material for cartilage repair. It was verified the formation of a surface skin, however 
a greater degree of pore interconnectivity (up to 57%) was found compared to that reported 
for the gas foaming technique applied to PLGA. In vitro cell culture revealed enhanced 
phenotypic maintenance of chondrocytes cultured on the foamed material (as measured by 
extracellular matrix secretion), demonstrating the utility of a three-dimensional environment 
for promoting tissue regeneration. Further optimisation of the processing conditions of 
PEMA/THFMA demonstrated that the degree of porosity and their interconnectivity could be 
tightly controlled simply by controlling the venting rate. In this process, an additional 
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porogen/leaching process is not necessary. As might be expected, as porosity increases, 
mechanical strength decreases and this is an important factor in many biomedical 
applications. There is therefore an upper limit, above which pore size and low mechanical 
strength precludes their use in certain applications.24 
In attempting to improve the mechanical properties of the THFMA for soft prosthetic 
applications, the foaming of blends of THFMA with styrene–isoprene–styrene copolymer 
elastomer has been investigated. Mechanical testing revealed the blends to be elastomeric, and 
these systems may therefore lend themselves to use as scaffolds for particular tissues, such as 
cartilage. The degree of porosity and interconnectivity of the pores could be tuned by 
modifying the blend composition and processing temperature, with a reduction in the degree 
of foaming as temperature increased.25 
Similarly, Mathieu et al.18 have shown that the morphology of the foams can be controlled 
to mimic the bone structure. They found that by controlling the cooling rate of the foamed 
polymer and the density of the gas nucleation similar bone structures could be formed. Rapid 
cooling creates many spherical pores while slower cooling permits pores elongation. 
Alternatively, the interconnectivity of the pores can be improved by post-processing the 
scaffolds generated by gas foaming using ultrasound. Wang et al.26 produced polymer foams 
of poly(lactic acid) (PLA) (using sub-critical pressures of CO2) and exposed them to pulsed 
ultrasound at a frequency of 20 kHz and average power input of 100 W. This not only slightly 
increased pore size, but also improved their interconnectivity as a result of pore wall rupture. 
2.2. Supercritical fluid emulsion templating 
An alternative to the use of supercritical fluids in the gas foaming of polymers to create 
porous scaffolds is emulsion templating. Here, a variety of porous hydrophilic materials can 
be produced by reaction-induced phase separation of concentrated oil-in-water emulsions. 
Conventional methods require large amounts of water immiscible organic phases as the 
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internal phase (usually > 75%), which can be difficult to remove after the reaction. For 
example, for inorganic materials temperatures > 600°C are often used, which would clearly 
not be appropriate for thermolabile materials or those containing growth factors for 
regenerative medicine. 
Butler et al.27 demonstrated that the emulsion templating principle can be applied to 
supercritical CO2-in-water (C/W) emulsions. Using perfluoropolyether (PFPE) surfactants 
and PVA to stabilize the C/W emulsions of acrylamide polymers, they vented the CO2 
following polymerization, leaving polymer scaffolds with interconnected pores (Figure 1.4). 
Increasing the volume fraction of the CO2 internal phase increased porosity, and increasing 
the surfactant concentration led to more open interconnected structures. 
 
Figure 1.4 - Schematic of the preparation of porous materials using supercritical fluid emulsion 
templating. The external phase is an aqueous solution and the internal droplet phase is scCO2 (adapted 
from Butler et al. 10). 
 
A disadvantage of this protocol for bioengineering applications is the use of a non-
degradable surfactant, and the mean pore sizes (~50 µm) produced may not be suitable for all 
applications — it has been reported that scaffolds for bone regeneration for example require 
pore sizes between 200 and 400 µm.28 
A variation on the emulsion templating technique has recently been reported by Partap et 
al.29, who produced emulsion templated alginate hydrogels in which the scCO2 not only 
served as the templating “oil” phase, but also as a source of acidity used to release Ca2+ from 
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its chelated form, freeing it to crosslink the alginate and form the porous hydrogel. Calling the 
technique “reactive emulsion templating”, they were able to produce 3D hydrogels with an 
open and interconnected porous network, with a mean pore size similar to the emulsion 
templating technique reported by Butler et al.10. 
2.4. Phase inversion 
The majority of porous membranes are prepared from a homogenous polymer solution by 
the wet phase inversion method. In this method, a homogeneous polymer solution is loaded 
on a support and immersed in a coagulation bath containing a non-solvent. The formation of 
the porous structure occurs due to the exchange of solvent and non-solvent that causes a 
decrease in solvent power and the polymer precipitates. So, the affinity between solvent and 
non-solvent, as well as polymer concentration, temperature, humidity, evaporation time and 
composition of the casting solution are very important parameters that allow the control of 
membrane morphology.11,12,13 
One of the main concerns when using this method is that some solvents are volatile, 
flammable and may cause risk to health and environment. For this reason and due to the 
presence of residual solvents that can cause potential problems in biomedical applications, 
membranes are normally submitted to intensive post-treatments. Moreover, long formation 
times and a limited possibility to modulate cell size and membrane structure characterize this 
process. 
Kho et al.30 used a new technique in which scCO2 is used to induce the phase separation of 
the polymer solution. Compared with the wet phase inversion method, advantages of this 
phase separation process can be: 
(1) ScCO2 can dry the polymer membrane rapidly and totally without the collapse of the 
structure due to the absence of a liquid–vapour interface. The dry membrane can be obtained 
without additional post-treatment because there are no traces of organic solvents. 
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(2) It is easy to recover the solvent; the solvent dissolved in scCO2 can be removed from 
gaseous CO2 in a separator located downstream the membrane formation vessel. 
(3) CO2 is not toxic, not flammable and low cost. 
Kho et al. used compressed CO2 for the formation of Nylon 6 membranes. A 15% (w/w) 
Nylon 6 polymer solution was prepared by dissolving Nylon 6 in 2,2,2-trifluoroethanol. Thin 
film with thickness ranging from 150 to 250 µm was obtained. The process was performed at 
35ºC with the final pressure up to 17.4 MPa, for 30 minutes. These authors obtained uniform 
structures with cellular pores 0.4 µm in diameter. They described the structural gradient and 
pore characteristics of the membranes by a competition between a liquid–liquid (L–L) 
demixing, that originates soft cellular pores and solid–liquid (S–L) demixing, that originates 
rough structures. The authors concluded that reducing the relative strengths of both the 
solvent and the non-solvent, led to membrane pore structures dominated by crystallization (S–
L demixing), that is the thermodynamically favoured demixing process, rather than L–L 
demixing, which is kinetically favoured. 
Another membranes formation process, in which scCO2 is used as non-solvent, has been 
presented by Matsuyama et al.31. The process consists of the introduction of CO2 into a 
membrane formation cell through a buffer tank using a valve that connects the two vessels. 
After the system has been equilibrated (for 15 minutes) at the pressure of 130 bar, a second 
valve is opened and CO2 flows in the cell to dry the phase-separated polymer solution. 
Matsuyama et al. studied the formation of thin polystyrene membranes analysing the effect of 
several process conditions (temperature, pressure, polymer concentration). They observed that 
the average pore size ranged from 8 to 35µm changing pressure (from 75 to 150 bar), polymer 
concentration (from 15 to 30% (w/w)) and temperature (from 20 to 70ºC). 
In a successive work, Matsuyama et al.32 studied the influence of different solvents used 
during the formation of cellulose acetate membranes. The authors worked with all fixed 
process parameters: pressure, temperature and polymer concentration (130 bar, 35ºC, 15% 
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(w/w)) and tested four solvents: acetone, methyl acetate, 1,3-dioxolane and 2-butanone. They 
noted that, as the mutual affinity between the solvent and CO2 decreases, the membrane 
porosity and the pores size increases. 
Using the scCO2 assisted phase inversion method, Reverchon and Cardea13 studied the 
formation of cellulose acetate membranes from acetone, polysulfone membranes from N-
methylpyrrolidone and chloroform, poly-L-lactide membranes from chloroform, and 
poly(methyl methacrylate) membranes from dimethylsulfoxide, acetone, and tetrahydrofuran. 
The overall result of these studies is that, changing the supercritical based process parameters, 
it is possible to modulate cell and pore size and to obtain various morphologies using the 
same liquid solvent: cellular structure, binodal structure, and microparticles. In some cases, it 
is also possible to modulate all membrane characteristics simply changing the non-solvent 
power of scCO2. 
Temtem et al. 11 studied the solvent affinity and depressurization rate on the morphology of 
polysulfone (PS) membranes produced by CO2-assisted phase inversion method, of six 
different organic solvents and two depressurization rates. This study showed that mutual 
affinity between solvent and non-solvent and the depressurization rate influence the 
membranes morphology when scCO2 is used as non-solvent. They also studied the 
preparation of membranes with polysulfone/polycaprolactone (PS/PCL) blends using a CO2-
assisted phase inversion method.12 The CO2 capability to swell PCL and decrease the Tm was 
used to produce and control the porosity and the properties of the membranes. In this study it 
was shown that CO2-assisted phase inversion method combined with the capability of CO2 to 
act as a blowing agent can be used to produce PS/PCL membranes. By adjusting the PS/PCL 
ratio it was possible to vary the morphology, the hydrophilicity and the mechanical 
performance of the membranes. This was the first attempt to combine CO2 foaming ability 
with phase inversion process for membranes production with polymer blends. 
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In conclusion the use of scCO2 as a non-solvent allows the preparation of sterile and ready 
to use devices, since CO2 is a gas under ambient conditions and can be easily removed from 
the polymeric product without leaving residues and, consequently, without requiring 
additional post-treatments.5 Moreover, it is possible to recover the solvent from CO2 during 
depressurization, mass transfer is improved (much lower viscosities than organic liquids, and 
easily adjusted with variations in pressure and temperature) and there is a better control of 
membranes morphology, due to the introduction of more parameters (pressure, CO2 flow, 
depressurization rate).11 
Even so, scCO2 has a low affinity to some solvents, namely water, at the ordinary process 
conditions (40-60ºC, 100-250 bar) being unable to produce membranes of water soluble 
polymers. The alternative is to use a co-solvent (ethanol, for instance) in addition to scCO2 
flow to increase the solubility of the solvent in CO233. The ratio of the co-solvent will also 
influence the membrane morphology and, as the other parameters, must be controlled in order 
to obtain porous structures with the desired morphology.34 
Figure 1.5 represents an isothermal phase diagram for the system polymer-solvent-non-
solvent (scCO2) at pressures above the critical point of the binary mixture solvent+CO2. As 
explained above, the affinity between solvent and non-solvent, as well as polymer and solvent 
are some of the parameters that must be controlled to obtain the desired membrane 
morphology. All possible composition combinations of the components can be plotted in this 
diagram, where the corners represent each intervenient: i) the polymer; ii) the solvent and iii) 
the non-solvent – (scCO2). The type of structures obtained and the pore dimensions are 
related with the thermodynamics and kinetics of the phase-inversion process, depending on 
the path through the ternary diagram.35,36 
The diagram presents a liquid-fluid region where the spinodal and binodal curves enclose 
demixing boundary. The point where the binodal and the spinodal coincide is the critical point 
and the region between the curves corresponds to a metastable state. 
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Nucleation and growth (usually a slow process) is the expected mechanism when a system 
leaves the thermodynamically stable condition and slowly enters the metastable region and 
can be represented in the ternary diagrams by the two distinguish paths: Path (4) –  demixing 
starts somewhere below the critical point – nucleation and growth of the polymer-rich phase 
occurs and microparticles are obtained. Path (2) – demixing starts somewhere above the 
critical point - nucleation and growth of the polymer-poor phase occurs with further 
solidification of the polymer-rich phase which forms a membrane cellular structure.  
Another mechanism is spinodal decomposition that occurs in a transition that crosses the 
metastable region near the critical point. Path (3) - demixing starts with concentration 
fluctuations of increasing amplitude, giving rise to two continuous phases, forming a 
bicontinuous (spinodal) membrane structure. 
Finally, Path (1) – demixing occurs when the outflow of the solvent from the solution is 
faster than the inflow of the non-solvent and the polymer molecules solidifies by gelation or 
crystallization into a dense structure. 
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Figure 1.5 – a) Schematic representation of an isothermal phase diagram for the system polymer-
solvent-non-solvent
 
at pressures above the critical point of the binary mixture solvent+CO2; b) 
obtained structures at different composition paths: (1) dense structure, (2) cellular morphology, (3) 
bicontinuous morphology and (4) microparticles (adapted from Temtem et al. 34). 
 
3. Freeze-drying method 
Besides SCF based techniques to prepare porous structures other conventional methods 
have been studied, including fiber bonding, particulate leaching, melt molding and emulsion 
freeze-drying.37 
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In emulsion freeze-drying, an emulsion is prepared by homogenization of a polymer–
solvent system. The continuous phase consists of the polymer-rich phase, while solvent is the 
dispersed phase. The emulsion is cooled down quickly to freeze the solvent and water by 
immersion in a freezing bath (for example, liquid nitrogen). This results in solidification of 
the polymer directly from the liquid state and the creation of porous polymer structure. 
Subsequently, the frozen solvent is removed by lyophilization38 (Figure 1.6). 
Several parameters must be controlled such as casting solution composition and freezing 
temperature to obtain the desirable pores morphology.39 This method has been used to 
fabricate aliphatic polyester-based scaffolds by Whang et al.40,41. Scaffolds with porosities 
higher than 90%, median pore sizes ranging from 15 to 35 µm with larger pores greater than 
200 µm were prepared. The scaffold pore architecture was highly interconnected what is 
essential for tissue ingrowths and regeneration.  
 
 
 
Figure 1.6 – Schematic representation of emulsion freeze-drying process (adapted from Whang et 
al.40). 
Scaffold 
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This technique has been devised for incorporating proteins into the polymer scaffolds. 
Freeze-drying of aqueous solutions of natural biopolymers such as collagen has been reported 
for the production of well defined porous matrices (i.e., pore size and orientation) based on 
the controlled growth of ice crystals during the freeze-drying process.37,42 Also, chitosan has 
been used as a structural base material for scaffolds production using freeze-drying process. 
Scaffolds with specific shapes and size and with control over pore morphology were prepared 
by Madihally et al.43 
However, the emulsion freeze-drying method is user and technique sensitive. The 
fabrication of a truly interconnecting pore structure depends on the processing method and 
parameters as well as on the used equipment.44,45 
 
4. Crosslinking process 
To enhance biostability and mechanical properties, scaffolds can be submitted to a physical 
or chemical crosslinking treatment. Physical processes consist in UV radiation, freeze-drying 
or heating; while in chemical processes it can be used ionic crosslinking or chemical 
crosslinkers such as glutaraldehyde and carbodiimide46. 
There are different crosslinking procedures described in literature. For example, PVA can 
be physically crosslinked by repeated freeze-thawing cycles of aqueous polymer solutions or 
chemically crosslinked with glutaraldehyde (Figure 1.7 (b)), succinyl chloride, adipoyl 
chloride and sebacoyl chloride. It can also be blended with other water-soluble polymer and 
again crosslinked either physically or chemically. Chitosan derivatives and blends have been 
chemically crosslinked using glutaraldehyde (Figure 1.7 (a)), epichlorohydrin or ethylene 
glycol glycidyl ether and physically crosslinked by UV radiation and thermal variations.47,48 
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Figure 1.7 - Schematic representation of (a) chitosan and (b) PVA crosslinked with glutaraldehyde 
(adapted from Li et al. 48).  
 
Glutaraldehyde is one of the most used chemical crosslinkers since it is less expensive than 
other reagents, is readily available and is highly soluble in aqueous solution. 
 
Figure 1.8 – Equilibrium of glutaraldehyde in aquous solution (adapted from Jayakrishnan and 
Jameela 49). 
 
There are different crosslinking procedures described in literature to prepare chitosan-based 
hydrogels and chitosan microspheres or membranes, using glutaraldehyde. Yao et al.50 
reported a procedure for the preparation of semi-interpenetrating hydrogel based on 
glutaraldehyde crosslinked chitosan with an interpenetrating polyether polymer network. 
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Gohel et al.51 reported on chitosan microspheres where glutaraldehyde was used as a 
crosslinking agent. Thacharodi and Rao52 studied propranolol hydrochloride delivery systems 
using various chitosan membranes with different crosslink densities as drug release 
controlling membranes. The drug release was significantly reduced when crosslinked chitosan 
membranes were used. Moreover, the drug release rate was found to depend on the crosslink 
density within the membranes. It was observed that the device constructed with a chitosan 
membrane with a high crosslink density released the minimum amount of drug. This is due to 
the decreased permeability coefficient of crosslinked membranes resulting from the crosslink 
points. 
One of the major concerns when using glutaraldehyde is its toxicity, which has lead to 
several studies. It was concluded that the operation time, concentration of the reagent and 
temperature were important parameters that should be optimized to reduce or eliminate 
toxicity due to glutaraldehyde. Also, Ruijgrok and De Wijn53 showed that not only the amount 
of reagent but also its nature and distribution are important. The crosslinker should be 
distributed uniformly throughout the thickness of the material. They showed that high 
temperature enhances the crosslinking and allows lower concentrations of glutaraldehyde. 
Thus, by optimizing the time, temperature and concentration of the reagent, it is possible to 
obtain a more uniform network.49 
 
5. Biomaterials in tissue engineering 
The search for materials with appropriate physical and chemical properties to apply in 
biomedical field has lead to intensive investigation.54,55,56 Ceramics and metals were studied 
by several researchers, including Ducheyne and Qiu57, Puleo and Nanci58 and Rosen et al.,59 
for orthopedic applications. Despite the contribution of these materials to major advances in 
the medical field, they are not biodegradable and their processability is very limited. Polymer 
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materials have received increasing attention and been widely used for tissue engineering 
because of easy control over biodegradability and processability.54 
Both natural and synthetic polymers have been studied for tissue engineering applications. 
The naturally derived polymers include proteins of natural extracellular matrices such as 
collagen and glycosaminoglycan, chitosan and polypeptides.60 Chitosan, a naturally derived 
polysaccharide is obtained by alkaline deacetylation of chitin, the principal component of 
protective cuticles of crustaceans such as crabs, shrimps, lobsters and cell walls of some 
fungi. Chitosan structure is represented in Figure 8, presenting one primary amino and two 
free hydroxyl groups for each C6 building unit. Due to the easy availability of free amino 
groups in chitosan, it carries a positive charge and thus in turn reacts with many negatively 
charged surfaces/polymers and also undergoes chelation with metal ions (Fukuda61). Thus, it 
is utilized for separation of metals. Chitosan is a weak base and is insoluble in water and 
organic solvents, however, it is soluble in dilute aqueous acidic solution (pH < 6.5), which 
can convert the glucosamine units into a soluble form R–NH3+. It gets precipitated in alkaline 
solution or with polyanions and forms gel at lower pH. It also acts as flocculant for the 
treatment of waste water. Properties such as biodegradability, low toxicity and good 
biocompatibility make it suitable for use in biomedical and pharmaceutical fields, for example 
it is used in wound62 and burn healing,63 in ophthalmology64 and in the form of membranes 
that were found useful as artificial kidney membranes because of their suitable permeability 
and high tensile strength.65 In spite of the advantages of this polymer there are certain 
limitations and concerns regarding their use. Lee et al.66 showed that it is difficult to control 
mechanical properties and degradation rates of the naturally derived polymers. 
Proper characterization and screening of the natural materials lighten many of the concerns, 
but overcoming the materials limitations is more challenging. Several approaches have been 
taken to overcome these limitations, including graft polymerization and blending with other 
natural or synthetic polymers. Polymer blends have shown favourable results in terms of the 
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targeted biological, mechanical or degradation properties in comparison to the individual 
components.54,55,56 
In the case of synthetic polymers, they can be tailored to have a much wider range of 
mechanical and chemical properties than natural polymers. They also avoid the concern 
regarding immunogenicity, but Seal et al.67 demonstrated that biocompatibility becomes a 
problem. For the purposes of biomaterials, synthetic polymers may be classified as non-
degradable and degradable polymers. Non-degradable polymers that are biocompatible and 
have been used extensively include poly(tetrafluoroethylene) (Teflon) for applications such as 
vascular grafts68 and high density polyethylene for use in hip implants,69 among other 
applications. While the non-degradable polymers can be fabricated with an extremely wide 
range of well controlled properties, their permanence does raise concern regarding their long-
term effects, especially with regards to wound and inflammatory response.70 
Thus, there has been a great deal of research into the development of degradable synthetic 
polymers which would, in theory, have all the properties of their non-degradable counterparts, 
but also avoid the long-term issues by degrading to metabolizable components.71 
PVA presents a good alternative to form a blend with chitosan because it is a biodegradable 
synthetic polymer, innocuous and biocompatible allowing its applications in biomedical field. 
Additionally it is highly hydrophilic and has an excellent chemical resistance and physical 
properties.63 The intermolecular interactions between the two polymers it is also important in 
the blend formation and morphology. In this case, due to its functional groups, chitosan is 
potentially miscible with PVA (Figure 1.9).72 
              
Figure 1.9 – Structures of chitosan and PVA (adapted from Bahrami et al. 73). 
Chitosan Poly (vinyl alcohol) 
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Chitosan membranes blended with PVA have already been reported to have good 
mechanical properties because of the specific intermolecular interactions between PVA and 
chitosan in the blends.74 Uragami et al.75 prepared crosslinked PVA/chitosan blend with a 
fixed amount of crosslinking agent and studied the active transport of halogen ion through the 
blend membrane. Kim et al.76 reported the pH sensitive swelling properties of crosslinked 
PVA/chitosan blend membrane. Chaung et al.72 reported that the use of PVA/chitosan blend 
membrane was more favourable for fibroblast cell culture than the single components and 
best suitable for wound dressing. 
Besides membranes, several researchers have also studied chitosan and PVA blended 
films77 and hydrogels78,79 for drug delivery and tissue engineering applications. 
In tissue engineering, the intent is to develop supports for tissue repair and regeneration, 
such as polymer matrices, formed by biocompatible and biodegradable materials.60 Initially, it 
was thought that cells might be able to organize into tissues and, ultimately, organ 
replacements if they were cultured in three dimensions under the appropriate reactor 
conditions. Refined considerably, this approach remains the foundation of this field. The 
matrices, also known as “scaffolds”, to create the three-dimensional environment have been 
designed with particular surface chemistries, architectures, and degradation rates to promote 
and direct cellular attachment, migration, proliferation, and differentiation (Yang et al.,80 
Chen et al.,60 Nguyen and West81). So, the biocompatibility of materials revealed to be of 
great importance in developing new structures for biomedical applications. There are several 
general characteristics that need to be considered for all scaffolds designs, although the final 
requirements depend on their specific purpose. The prepared structures must mimic the native 
extracellular matrix, an endogenous substance that surrounds cells, attach them into tissues 
and provide signals that help cellular development and morphogenesis.38,60 In addition, 
scaffolds should absorb body fluid for transfer of cell nutrients and metabolites through the 
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material, which is managed by the pore structure. For this reason, it is very important to create 
devices with a high porosity and good pore interconnectivity to promote cell adhesion and 
growth, allowing nutrient delivery, waste removal, protein transport, gaseous exchange and 
general vascularization.82 Besides, the mechanical properties of the matrices should match 
those of the tissue at the implantation site or at least protect the cells from compressive or 
tensile forces that may damage them. The matrices must be formed by biocompatible and 
biodegradable materials, bioadsorbed after a determined time period and replaced by grown 
tissue.60 
In Figure 1.10 it is represented the principle of tissue engineering: cells are isolated from a 
donor tissue and cultured on a scaffold in vitro and then implanted in vivo.38 
 
 
Figure 1.10 - The principle of tissue engineering (adapted from Stamatialis et al. 38). 
 
So, besides scaffolds, it is also important to study the cells to be implanted. Cell sources for 
tissue engineering have expanded tremendously, and fully differentiated cells, progenitors, 
and stem cells have shown great promise for the creation of the highly complex, functional 
tissues needed to address the tissue and organ loss in medicine (Shamblott et al.;83 Morrison et 
al.;84 Solter and Gearhart;85 Gage;86 Boheler et al.;87 Jackson et al.88). However, there are 
significant issues that must be understood and addressed to realize this potential. In particular, 
while stem cells and progenitors of various origins have been shown to differentiate into a 
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variety of cell types and, in some cases, form functional tissues (Levenberg et al.89), it 
remains challenging to differentiate the progenitors and stem cells in a controlled, efficient, 
and reproducible manner which results in terminally differentiated tissue structures. Tissue 
engineering may provide a means to gain critical insight into the behaviour of stem cells, by 
facilitating the control of the stem cell environment both chemically and physically in three 
dimensions. This, in turn, may lead to the development of new tissue substitutes and 
replacements.54 
 
6. Aim and outline of this thesis 
The conventional methods for the production of porous structures are either multi-step 
processes or needing organic solvents but the production of solvent-free structures is possible 
by using SCF technology. Although there are numerous examples of porous structures 
formation with SCF, the scCO2-assisted phase inversion method is one of the most used in 
membranes production. A method that does not use SCF, but it is applied in the production of 
3D-scaffolds highly porous and with good pore interconnectivity, to support cell adhesion and 
growth, is the freeze-drying method.82 
The aim of this thesis is to develop chitosan and PVA blended scaffolds with biocompatible 
and biodegradable properties for biomedical applications by means of SCF technology. 
The present chapter gives a general overview of SCF techniques used in scaffolds 
production, explains the freeze-drying method and presents a summarized description of the 
crosslinking process. In chapter I, the importance of biomaterials in tissue engineering is also 
reported. 
Chapter II comprises the preparation of chitosan and PVA blended membranes and 3D-
scaffolds, their characterization and the evaluation of biodegradable and cytotoxic tests in 
these porous structures. The scCO2-assisted phase inversion technique was the elected method 
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to prepare membranes with different PVA ratios to study the influence of the casting solution 
composition in the structures morphology. The 3D-scaffolds will be prepared using freeze-
drying technique and treated by means of scCO2-assisted crosslinking process. The influence 
of different casting solution compositions and percentages and different freezing temperatures 
in the scaffolds morphology will be analysed. The crosslinking process will also be an 
important aspect of this work and it will be studied for different crosslinker percentages and 
operation times. The characterization of membranes and scaffolds includes the determination 
of the mechanical properties (dynamic mechanical analysis (DMA)), morphology (scanning 
electron microscopy (SEM)), porosity (mercury porosimetry), hydrophobicity (contact 
angles), swelling and in vitro biodegradability. Finally, the cytotoxicity of membranes and 
3D-scaffolds will be evaluated, following International Standard guidelines, to conclude about 
the possible use of these devices to sustain stem cell function and proliferation for application in 
clinical settings. 
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II. Porous structures – Membranes and 3D-scaffolds 
1. Introduction 
The development of supports for tissue repair and regeneration is the base of tissue 
engineering.1 These supports must present appropriate characteristics like a high porosity and 
good pore interconnectivity to promote cell adhesion and growth and be mechanically 
strong.2,3 A commonly used material in biomedical field is chitosan, a naturally derived 
polymer, biocompatible and biodegradable. Even so, there are some difficulties in controlling 
mechanical properties and degradation rates when using this material and one of the 
possibilities to suppress these limitations is blending chitosan with other natural or synthetic 
polymer.4 In this work, chitosan was blended with PVA, a biodegradable synthetic polymer, 
highly hydrophilic,5 innocuous and biocompatible, allowing its applications in biomedical 
field.6 
There are several methods available to prepare porous structures with different 
morphologies, including gas foaming,7 emulsion templating,8 phase inversion9,10 and 
emulsion freeze-drying,11 and each one of these methods presents advantages and 
disadvantages. The use of SCF can minimize or eliminate some of the existing problems 
when preparing the matrices using conventional methods, like the use of organic solvents and 
the necessity of post-treatment processes.12 The most used SCF is supercritical carbon dioxide 
(scCO2) because it is an environmentally benign solvent, non-toxic, non-flammable and with 
an easily accessible critical point (Tc=31.1°C and Pc=7.38 MPa). Membranes in this work 
will therefore be prepared using CO2-assisted phase inversion method, where scCO2 is used as 
non-solvent. This method will allow the preparation of sterile and ready to use devices, since 
CO2 is a gas under ambient conditions and can be easily removed from the polymeric product 
without leaving residues and, consequently, without requiring additional post-treatments.13 
Moreover, it is possible to recover the solvent from CO2 during depressurization and there is a 
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better control of membranes morphology, due to the existence of several process parameters 
(pressure, CO2 flow, depressurization rate).9,10 
Freeze-drying method was used to prepare 3D-scaffolds, to promote a high porosity and the 
formation of large pores.3 All the other available methods presented some limitations and 
were more complexes. In this case SCFs were not used in the production of the porous 
structures, however to enhance biostability and mechanical properties, scaffolds were 
submitted to a chemical crosslinking treatment using glutaraldehyde by means of SCF 
technology.14 This last step was optimized in this work, varying operation time and 
concentration of glutaraldehyde. 
A detailed characterization of the 3D-scaffolds and membranes was made through the 
determination of the morphology (scanning electron microscopy), porosity (mercury 
porosimetry), hydrophobicity (contact angles and swelling measurements) mechanical 
properties (dynamic mechanical analysis) and in vitro biodegradability. In addition, 
membranes and 3D-scaffolds were evaluated in terms of cytotoxicity using International 
Standard guidelines15,16 in collaboration with researchers from IST. 
 
2. Experimental 
2.1. Materials 
Chitosan (75-85% deacetylated, Mw=(190-310) kg mol-1), PVA (≥99% hydrolyzed, 
Mw=(89-98) kg mol-1), absolute ethanol (purity≥99.5%), glacial acetic acid (purity≥99%), 
glutaraldehyde solution (50 wt.% in H2O), phenol (purity≥95%), crystal violet, accutaseTM, 
paraformaldehyde, phosphate buffered saline (PBS) and lysozyme from chicken egg white 
(50,800 U/mg protein) were purchased from Sigma-Aldrich and sodium acetate tri-hydrate 
(purity≥99.5%) from Riedel-De-Haën. RPMI-1640 (a Roswell Park Memorial Institute 
medium), Dulbecco’s modified essential medium low glucose (DMEM-LG), anti-Human 
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CD105, trypan blue and fetal bovine serum (FBS) used in cell culture were purchased from 
Invitrogel. L929 cells were obtained from DSMZ, Germany and WST-1 Proliferation Kit 
from Roche. Carbon dioxide was obtained from Air Liquid with 99.998% purity. All 
materials and solvents were used as received without any further purification. 
2.2. Membranes preparation 
The high pressure apparatus and experimental procedure used in membranes preparation 
was described by Temtem et al.9,10 A schematic diagram of the high pressure apparatus is 
represented in Figure 2.1 and supported by a photograph of the equipment in Figure 2.2. 
 
Figure 2.1 – Schematic diagram of the high pressure apparatus used where (1) Gilson 305 Piston 
Pump; (2) Gilson 306 Piston Pump; (3) Temperature controller (Hart Scientific, Model 2200); (4) 
High pressure cell; (5) Pressure transducer (Setra Systems Inc., Model 204); (6) Back pressure 
regulator (Jasco 880-81); (7) Water recirculating pump; (8) Visual thermostated water bath 
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Figure 2.2 – Photograph of the experimental high pressure apparatus and detail of the high pressure 
cell. 
 
The casting solution (4% w/w) is prepared dissolving chitosan and PVA in acetic acid (1% 
v/v) at 90ºC with stirring. The homogeneous solution at room temperature is loaded into a 
stainless steel cap (diameter of 68 mm and 3 mm height) and placed inside a high pressure 
vessel. The vessel is rapidly closed and immersed in a visual thermostated water bath at 60ºC, 
maintaining the temperature within ±0.01 ºC by using a controller (Hart Scientific, Model 
2200). A non-solvent flow is added using two Gilson piston pumps (models 305 and 306) 
until 20 MPa is reached and the operation is performed in continuous mode with a constant 
flow rate of 4.9 g/min. The non-solvent is a binary mixture of 97.5% CO2 and 2.5% ethanol 
(co-solvent) with a constant composition (isocratic mode)17. A back pressure regulator (Jasco 
880-81) allows the control of pressure inside the vessel and the separation of CO2 from the 
acetic acid used in the casting solution. The pressure inside the system is monitored with a 
pressure transducer (Setra Systems Inc., Model 204) with a precision of ±100 Pa. 
Four membranes with different ratios of chitosan and PVA were prepared using different 
operation times (Table 2.1) until all the solvent is removed. After that time period, a pure CO2 
flow is passed through the system during one hour to remove the ethanol. At the end, the 
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system is slowly depressurized during 10 minutes and a homogeneous membrane is obtained 
(Figure 2.3). 
 
Table 2.1 – Composition of membranes and operation time 
Membranes Chitosan (%) PVA (%) Operation time (hour) 
100CHT 100 0 6 
90CHT 90 10 10 
75CHT 75 25 12 
50CHT 50 50 16 
 
     
Figure 2.3 – Pictures of the chitosan membrane in the stainless steel cap immediately after preparation 
and removal from the high pressure cell: (a) top view and (b) lateral view. 
 
Another simple method used for membranes production is solvent evaporation. This method 
was applied to prepare a membrane and to compare its properties with the properties of the 
membranes prepared using scCO2 technology. For this membrane, it was used the same 
casting solution (4% w/w) and the same stainless steel cap as for the others membranes. The 
cap loaded with the casting solution was placed in a dryer at 60 ºC during 8 hours to 
(a) (b) 
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evaporate the solvent and form the membrane. In this case the prepared membrane is only 
composed by chitosan and defined as 100EVAP. 
 
2.3. Scaffolds preparation 
Scaffolds were prepared by freeze-drying method, as described by Madihally et al.1 The 
casting solutions with concentrations of 1, 2 or 3% (w/w) are prepared dissolving chitosan 
and PVA in acetic acid (1% v/v) at 90ºC with stirring. The homogeneous solutions at room 
temperature are placed in sample tubes with an inner diameter of 1.2 cm and 3 cm height. 
Different sample tubes are immersed in different freezing baths maintained at -20ºC, -50ºC or 
-196ºC during 1 hour and lyophilized until dry in a Telstar cryodos-50. Refrigeration baths 
containing ethanol were used to obtain the temperatures of -20ºC and -50ºC and liquid 
nitrogen to obtain -196ºC. Table 2.2 summarizes the chitosan scaffolds (100CHT) produced 
for different compositions and freezing temperatures. Blended scaffolds of chitosan and PVA 
were prepared in the same ratios as membranes (90CHT, 75CHT and 50CHT) for the same 
compositions and freezing temperatures as 100CHT scaffolds. 
 
Table 2.2 – Summary table of 100CHT scaffolds for different operation conditions 
                  Freezing 
Temperature 
                   (ºC) 
Composition 
    (% w/w) 
-20 -50 -196 
1 100CHT_1% -20ºC 100CHT_1% -50ºC 100CHT_1% -196ºC 
2 100CHT_2% -20ºC 100CHT_2% -50ºC 100CHT_2% -196ºC 
3 100CHT_3% -20ºC 100CHT_3% -50ºC 100CHT_3% -196ºC 
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The scaffolds were then treated with glutaraldehyde on a high pressure apparatus similar to 
the one used in membranes preparation, but in this case using an additional high pressure cell 
where the crosslinker is placed, as represented in Figure 2.4. 
 
Figure 2.4 – Schematic diagram of the high pressure apparatus used where (1) Gilson 305 Piston 
Pump; (2) Gilson 306 Piston Pump; (3) Temperature controller (Hart Scientific, Model 2200); (4) 
High pressure cell containing the scaffold samples; (5) Pressure transducer (Setra Systems Inc., Model 
204); (6) Back pressure regulator (Jasco 880-81); (7) Water recirculating pump; (8) Visual 
thermostated water bath; (9) High pressure cell containing glutaraldehyde solution 
 
Initially, a CO2 flow passes through the high pressure cell (9), where the crosslinker agent 
was placed, to saturate the CO2 stream in glutaraldehyde. Opening the valve V3, the high 
pressure cell (9) is placed in contact with the high pressure cell (4), where the scaffold 
samples were previously sited. During a determined period of time, the CO2 saturated in 
glutaraldehyde at a constant flow rate of 9.8 g/min passes through the high pressure cell (4) 
and contacts with the scaffold samples. Pressure (20 MPa) and temperature (40 ºC) are 
controlled as described in membranes preparation. After crosslinking treatment, the high 
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pressure cell (9) is disconnected of the system and a pure CO2 flow passes through the high 
pressure cell (4) during one hour to clean the remaining residues of glutaraldehyde. At the end 
of operation, the system is slowly depressurized during 10 minutes. 
This crosslinking process required an optimization and therefore different operation times 
and glutaraldehyde concentrations were tested (Table 2.3). Later on, it became necessary to 
increase the scaffolds diameter for cell culture tests, so a sample tube with different 
dimensions, an inner diameter of 1.8 cm and 4 cm height, was used and once more the 
operation time of the crosslinking process had to be studied (Table 2.4). 
 
Table 2.3 – Operation conditions for crosslinking process using a sample tube with an inner 
diameter of 1.2 cm and 3 cm height 
3D-scaffolds 
Glutaraldehyde 
concentration (% (v/v)) 
Operation Time 
(minutes) 
0.1%GTA_10min 0.1 10 
1%GTA_10min 1 10 
50%GTA_10min 50 10 
50%GTA_1H 50 60 
 
Table 2.4 – Operation conditions for crosslinking process using a sample tube with an inner 
diameter of 1.8 cm and 4 cm height 
3D-scaffolds 
Glutaraldehyde 
concentration (% (v/v)) 
Operation Time 
(minutes) 
1%GTA_10min(2) 1 10 
1%GTA_30min 1 30 
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2.4. Characterization 
Morphological and physico-chemical properties 
Membranes and scaffolds were characterized using scanning electron microscopy (SEM) in 
a Hitachi S-2400, with an accelerating voltage set to 15 kV. For cross-section analysis the 
samples were frozen and fractured in liquid nitrogen. All samples were coated with gold 
before analysis. The porosity, characteristic length values and pore size distribution were 
obtained in a mercury intrusion porosimeter, AutoPore IV 9500 Micromeritics. Mercury was 
filled progressively, changing from a filling pressure of 345 kPa to 414 MPa. Membranes 
hydrophobicity was evaluated through the measurement of the contact angle of water droplets 
in a KSV Goniometer Model CAM 100. 
 
Mechanical properties 
The dynamic mechanical analysis (DMA) experiments were performed in a Minimat firm-
ware v.3.1 (Figure 2.5) using the tensile mode. The membranes were cut into strips with 2x15 
mm
2 and the thickness was measured using a vernier caliper. The length between the clamps 
was set at 5 mm, using a full scale load of 20 N, a maximum extension of 90 mm and a speed 
testing of 0.1 mm/min. Measurements were performed with dry and wet membranes at room 
temperature. For testing in wet state, the samples were soaked in PBS solution for 1 hour and 
then placed in the device, being continuously wetted with this solution. Load extension graphs 
were obtained during testing and converted to stress strain curves applying the following 
equations: 
)2(
)1(
L
lStrain
A
FStress
∆
==
==
ε
σ
 
where F - applied force, A - cross sectional area, ∆l - change in length, L - length between 
clamps. 
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Figure 2.5 - Photograph of the (a) DMA equipment and (b) detail of the membrane sample placed 
between the two clamps. 
 
Swelling measurements 
The swelling tests were performed to determine the water uptake in membranes and 
scaffolds. Dry membrane samples were weighted and immersed in beakers containing 20 mL 
of PBS solution at 37ºC during 1 week. Then, the samples were weighted, after removing the 
excessive water. Swelling measurements for crosslinked scaffolds involved dynamic tests, 
using pH variations. Initially the scaffold samples were weighted and immersed in beakers 
containing 20 mL of PBS solution at pH 7.4 and 37ºC. Periodically, the samples were 
removed from the swelling medium, wiped to remove excessive water of the surface and 
weighted. After 24 hours, when the mass of the scaffolds reached a plateau value, the samples 
were transferred to a pH 5 medium (acetate buffer saline solution 0.1 M) at 37ºC. After 
another 24 hours, a new plateau was reached, and the samples were transferred to the pH 7.4 
medium. This dynamic swelling and shrinking was studied during 5 days. Swelling degree (W 
(%)) of the samples was determined as defined by: 
)3(100(%) ×−=
d
dw
W
WWW  
where Wd is the weight of the dried sample and Ww is the weight after immersion. 
(a) (b) 
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2.5. In vitro biodegradation studies 
The degradation of membranes and scaffolds in vitro was studied by degrading chitosan in 
PBS solution at 37ºC containing 2 µg/mL of lysozyme. The concentration of lysozyme was 
chosen for being similar to the concentration in human serum as reported by other authors.18,19  
The initial weight of each sample was determined (Wi). After specific time intervals, samples 
were removed from the medium, washed with distilled water, freeze-dried and weighted. The 
lysozyme solution was refreshed weakly to ensure continuous enzyme activity. The extent of 
degradation was expressed as a percentage of remaining weight. To distinguish enzymatic 
degradation from dissolution, the control samples were stored under the same conditions as 
described above but without the addition of lysozyme. Percentage remaining weight was 
calculated using the following equation: 
)4(100100(%)








×
−
−=
i
fi
W
WW
weightemainingR  
where Wi is the initial dry weight of sample and Wf is the dry weight of sample after 
degradation. 
 
2.6. Cytotoxicity assay 
The membranes were tested for cytotoxicity following the ISO 10993-5 guidelines. Briefly, 
triplicates of 1 cm2 membranes and scaffolds were placed in polystyrene tubes containing 3 
mL of RPMI – 1640 with 10% (v/v) of FSB and kept in an incubator (37ºC, 5% CO2, fully 
humidified) for 3 days. The liquid extracts were used to culture L929 mouse fibroblasts 
(initial density 80x103 cells/cm2) in 24-well plates for 2 days. The cell metabolic activity was 
determined by analyzing the conversion of WST-1 (light red) to its formazan derivative (dark 
red – absorbance at 450 nm after a 2.5 hours incubation at 37ºC) using a WST-1 Cell 
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proliferation kit. The results were normalized to the negative control for cytotoxicity (fresh 
RPMI medium) and compared to the positive control (0.01M Phenol). 
In order to evaluate the effect of the direct interaction between the membranes and the L929 
cells, samples were conditioned with RPMI medium (2 cm2/mL) overnight before cell seeding 
in 24 well-plates (6000 cells per well). At day 3 of culture, cells cultured on the membranes 
were stained with crystal violet and then observed under an inverted light-phase microscope 
(Olympus) in order to qualitatively evaluate the morphology, cell-to-cell contact and 
attachment. Briefly, cells were washed with PBS solution and then stained with crystal violet 
(0.5% (w/v) in methanol) for 30 minutes, washed three times with PBS solution and then 
observed. 
In scaffolds the direct interaction between the samples and the L929 cells was also 
evaluated. In this case, samples were conditioned with RPMI medium (2 cm2/mL) overnight 
before cell seeding in 24 well-plates (6000 cells per well). At day 3 of culture, cells cultured 
on the scaffolds were stained with DAPI [2-(4-Amidinophenyl)-6-indolecarbamidine] and 
then observed by fluorescence microscopy in order to qualitatively evaluate the morphology, 
cell-to-cell contact and attachment. Briefly, cells were fixed with 0.5 mL of 1% 
paraformaldehyde for 20 minutes at room temperature and washed, once again, with PBS. 
Then, the cells were incubated in the dark with 0.5 mL of DAPI (1.5 µg/mL in PBS, prepared 
from a 1 mg/mL in PBS stock solution) for 5 minutes at room temperature, protected from 
light and washed again with PBS. DAPI stains blue the intact deoxyribonucleic acid (DNA) 
and the stained nuclei can be visualized under an ultraviolet light (Olympus U-RFLT50). 
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3. Results and discussion 
3.1. Membranes preparation and characterization 
When preparing membranes using CO2-assisted phase inversion method several parameters 
have to be controlled to obtain the desired structures, namely the solvent used in the casting 
solution, the concentration of polymer in the casting solution, the co-solvent composition, the 
pressure, the temperature and the depressurization time. In this work the former process 
parameters were fixed to study the influence of two additional important parameters in the 
membranes formation: the casting solution composition and the operation time. This method 
has been widely studied, but was never applied to prepare blended membranes of chitosan and 
PVA. In this particular case the main objective is to study the influence of the PVA ratio in 
the morphology and in biological, mechanical and degradation properties of the prepared 
membranes. The variation in the operation time only happened because the casting solution 
composition influenced the membrane formation. So, the operation time used in each case 
was the enough time to obtain the membrane. 
 
The use of SEM allows the observation of the membranes morphology and their 
comparison. Figure 2.6 shows the SEM images of the cross section and top view of the 
different membranes and it is possible to note a strong dependence of membranes morphology 
with the PVA ratio on the casting solution. It can be observed that 100CHT presents pores 
with elongated shape and with increase of PVA ratio, pores become more spherical, with 
smaller diameters and the membranes surface becomes irregular. Mercury porosimetry was 
used to complement the information about pore size and porosity of the membranes. The 
porosity values and characteristic length, which is an indicator of the interconnectivity 
between pores, for the different membranes are presented in Table 2.5. The results obtained 
with this technique showed that all the membranes have a low porosity, which decreases as 
the ratio of PVA in the casting solution increases. So, 100CHT presents a porosity of 36%, 
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90CHT 25%, 75CHT 22% and 50CHT 16%. The porosity values for 100CHT are similar to 
the ones find in literature for chitosan membranes.20 Even so, the membranes with PVA 
content revealed a higher characteristic length than 100CHT. This membrane only presented a 
characteristic length value of 3.3 µm, while 50CHT presented 35.9 µm. These results suggests 
higher interconnectivity between pores in membranes with PVA content, and this fact may be 
related with the irregular surface and different pore shapes on these membranes as revealed in 
SEM images. Membranes produced by solvent evaporation, 100EVAP, and 100CHT have 
similar porosity values, but 100EVAP presents much less interconnectivity between pores 
(0.027 µm). 
 
Table 2.5 – Influence of composition in membranes morphology 
Membranes Porosity (%) Characteristic length (µm) 
100CHT 36 3.3 
90CHT 25 18.4 
75CHT 22 34.4 
50CHT 16 35.9 
100EVAP 34 0.027 
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Figure 2.6 – SEM images of cross-section and surface top view of membranes with different PVA 
content: a) 100CHT; b) 90CHT; c) 75CHT; d) 50CHT; e) 100EVAP. 
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To increase the porosity of the blended membranes the process parameters could be 
modified. Temtem et al.17 studied the influence of the co-solvent composition as well as the 
influence of the co-solvent operation mode (gradient or isocratic) in chitosan membranes 
morphology. An increase in the ethanol ratio in the co-solvent would increase the membranes 
porosity, but, for example, the use of 10% ethanol generates particles and not membranes. It 
was also demonstrated that the gradient mode allows the production of membranes with larger 
pores in comparison with the isocratic mode. Reverchon et al.21 studied the influence of the 
co-solvent ratio, the process temperature and pressure on PVA membranes formation. The 
manipulation of these three parameters allowed the preparation of PVA membranes with 
different morphologies. 
The CO2-assisted phase inversion revealed to be a flexible method in membranes 
preparation, allowing the control of membranes morphology through the manipulation of the 
process parameters. In this work, chitosan and PVA blended membranes with different 
morphologies were prepared using this method only varying the composition of the casting 
solution but, as previously described, other process parameters could also be tailored to 
modify the membranes morphology and prepare different porous structures with interesting 
potential applications. 
 
The contact angle of water droplets in the top-surface of membranes was measured to 
determine the relationship between membranes composition and hydrophobicity. The results 
presented in Table 2.6 show that there is a clear dependence between the contact angle and the 
PVA ratio on blended membranes. 100CHT has the most hydrophobic surface in comparison 
with the surface of the other prepared membranes, since it has the higher contact angle of 
111º. It was also observed that the contact angle decreases with the increase of PVA content, 
indicating an augment of polar groups at the surface, in agreement with the fact that PVA 
molecules are more hydrophilic than chitosan molecules. Even so, it must be noted that 
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contact angle also depends on the surface roughness and porosity. In SEM images it was 
noticed that the membranes with PVA content have an irregular surface, particularly 50CHT, 
what will cause a decrease in contact angle value. Although the difference is not very 
significant, the membranes production method also affects the hydrophobicity of the 
membranes surface; when using the evaporation method (100EVAP) the contact angle of the 
membranes was 105º, smaller than for the membranes produced by CO2-assisted phase 
inversion method (100CHT). Another publication22 present similar values for blended films of 
chitosan and PVA, where the higher contact angle was obtained for chitosan films (83º) and a 
lower value from the blend 50% chitosan/50% PVA (56º). Chen et al. mention that although 
both PVA and chitosan are hydrophilic polymers, their water contact angle is still high. 
Considering the membranes in this work, the values are even higher and that may be 
associated with the hydrophobic backbone of the polymers chains, with the dense surface of 
membranes and/or with the polar groups at the surface. 
In Table 2.6 are also included the swelling tests data obtained by determination of the water 
uptake in membranes. The membrane samples soaked in PBS solution (pH 7.4) at 37ºC 
during 1 week presented similar swelling values around (230-242)%, except for 50CHT with 
a higher swelling degree (284+/-7)%. Therefore, only the presence of a great amount of PVA, 
a highly hydrophilic polymer, will significantly increase the swelling values of membranes. 
These results are in accordance with the contact angle measurements, reinforcing the idea that 
the membranes hydrophilicity is dependent of the PVA content of the blends. Similar results 
for chitosan and PVA blended membranes were obtained by Mangala et al.23. The membrane 
prepared by solvent evaporation (100EVAP) partially dissolved in solution and it was not 
possible to determine the water uptake after 1 week. 
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Table 2.6 – Influence of membranes composition in contact angle and swelling degree 
Membranes Contact angle (º) Swelling degree (%) 
100CHT 111 +/- 5 236 +/- 8 
90CHT 92 +/- 6 230 +/- 5 
75CHT 86 +/- 4 242 +/- 6 
50CHT 75 +/- 3 284 +/- 7 
100EVAP 105 +/- 2 - 
 
Membranes were submitted to tensile tests performed under dry and wet conditions to 
determine the influence of membranes composition in mechanical properties. These tests 
provide an indication of the strength and elasticity of the membranes which are important 
factors considering their potential applications. Figure 2.7 presents the stress-strain curves for 
membranes under dry and wet conditions. The tests performed in dry membranes (Figure 2.7 
(a)) revealed that they all have an initial elastic behaviour for 8% strain, approximately, and 
after this value the stress exceeds a critical value undergoing plastic deformation. The higher 
stress values were supported by 100CHT, reaching 80 MPa and the elongation at break was 
20%, similar to the results obtained in literature for chitosan films24 and membranes 25. As the 
PVA ratio increases, membranes revealed the ability to undergo a longer elongation at break, 
reaching 116% for 50CHT, but supported lower break stresses. 100EVAP presented similar 
stress values in comparison with 100CHT, but the strain at break was only 8%, presenting no 
plastic deformation. The differences between the stress-strain behaviour of dry and wet 
membranes are very significant. Membranes under wet conditions (Figure 2.7 (b)) revealed an 
exclusive elastic behaviour, with lower break stresses (1-2 MPa) and higher elongation values 
(72-113%) than dry membranes. The only exception is 50CHT that present both elastic and 
plastic behaviours and the elongation at break was similar in dry and wet states. Also, 
100EVAP in wet state supported very low stress values. 
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Figure 2.7 - Stress-strain curves obtained for the membranes under (a) dry conditions and (b) wet 
conditions (soaked in PBS during 1 hour). 
 
The Young’s modulus or elastic modulus (E) is a mechanical parameter that gives 
information about membranes stiffness and it is defined as the slope of the stress-strain curve 
(E=stress/strain) in the elastic deformation region. The results presented in table 2.7 shows 
that the stiffness depends of the membranes composition and, as expected, the Young’s 
modulus values are lower in wet state than in dry state. The values obtained for 100CHT in 
dry and wet states are in agreement with the data from literature24,25. The blended membranes 
(a) 
(b) 
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presented lower values of Young’s modulus as the ratio of PVA increases, except for 50CHT 
in dry state. A possible explanation for this fact is that the membrane 50CHT presents a very 
low porosity and an irregular surface, affecting the membrane response to the tensile tests. 
 
Table 2.7 – Influence of membranes composition in Young’s modulus 
Young’s modulus (MPa) 
Membranes 
Dry state Wet state 
100CHT 1075 4.3 
90CHT 729 2.8 
75CHT 709 2.6 
50CHT 906 1.6 
100EVAP 1338 0.03 
 
3.2. Scaffolds preparation and characterization 
3D-scaffolds were prepared using freeze-drying method in order to obtain high porous 
structures. In this method, as in others, the operation parameters must be controlled to 
produce matrices with the desired properties in accordance with their application. The 
freezing temperature, polymer percentage and composition of the casting solution are some of 
the parameters that affect the morphology and may influence the biological, mechanical and 
degradation properties of the scaffolds. So, different scaffolds were prepared and studied for 
freezing temperatures of -20ºC, -50ºC and -196ºC, with different PVA ratios and using 1, 2 
and 3% (w/w) of the casting solution. 
Initially, the effect of the casting solution concentration was evaluated, for a constant 
composition (75%CHT/25%PVA) and a freezing temperature of -196ºC. The results of 
mercury porosimetry for casting solutions with concentrations of 1, 2 and 3% (w/w) revealed 
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similar pore size diameters, as well as porosity and characteristic length values (Table 2.8). 
The main difference between these structures is their stiffness behaviour that increases with 
higher polymer content. In literature it is said that the mechanical properties of the matrices 
should match those of the tissue at the implantation site or at least protect the cells from 
compressive or tensile forces that may damage them1. Therefore, the 3D-scaffolds prepared 
with 3% (w/w) of the casting solution were used in the following studies due to its stiffness 
structure, appropriate for most biomedical applications. 
 
Table 2.8 – Influence of the casting solution concentration in pores morphology of 3D-
scaffolds 
3D-scaffolds Porosity (%) Characteristic length (µm) 
75CHT_1% -196ºC 93.3 34.6 
75CHT_2% -196ºC 93.2 34.9 
75CHT_3% -196ºC 91.8 36.4 
 
For the same composition and concentration of the casting solution (100CHT and 3% 
(w/w)) and different freezing temperatures, scaffolds prepared at -20ºC have bigger pores than 
the scaffolds prepared at -50ºC and -196ºC (Figure 2.8 (a)). The distribution of pore size 
diameter for a freezing temperature of -20ºC presents a maximum at 40.6 µm, while for -50ºC 
and -196ºC the higher values were 11,3 µm and 13,9 µm, respectively. Facing these results, 
the subsequent experiences were made using freezing temperatures of -20ºC. At this 
temperature it is possible to obtain scaffolds with bigger pores, which will help to promote 
cell adhesion and growth and allow nutrient delivery, waste removal, protein transport, 
gaseous exchange, and general vascularisation. These aspects are described in literature as 
essential in scaffolds design.26 
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The objective at this moment is to determine the effect of the PVA ratio in 3D-scaffolds 
pore size, keeping a constant freezing temperature of -20ºC and the casting solution with 
polymer concentration of 3% (w/w). The results in Figure 2.8 (b) show that 100CHT present 
the higher values of pore size diameter followed by 90CHT with 40.62 µm and 32.91 µm, in 
that order. In comparison with these results, 75CHT and 50CHT present smaller pores, 
although larger distributions, showing a wide range of pores size. In addition, scCO2-assisted 
crosslinking with glutaraldehyde showed no influence on pores morphology of the scaffolds. 
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Figure 2.8 – Influence of: (a) freezing temperature and (b) composition in the pore size diameter of 
3D-scaffolds prepared with 3% (w/w) of polymer. 
 
(b) 
(a) 
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Figure 2.9 (a) is a picture of a scaffold sample prepared at -20ºC and using the casting 
solution with 3% (w/w) of polymer concentration, where it is possible to observe the high 
porosity of the structure. The SEM images in Figure 2.9 (b) and (c) allows the observation of 
the pores morphology in different regions of another scaffold sample prepared at -50ºC and 
using the casting solution with 3% (w/w) of polymer concentration. There were observed no 
significant differences in the pores morphology for scaffolds prepared at different freezing 
temperatures. It was also noticed that the blended structures with PVA in their composition, 
were less rigid than the chitosan scaffolds and observing the SEM images in Figure 2.9 it is 
possible to note the difference between scaffolds with and without PVA. 
The dynamic swelling tests were performed to determine the water uptake in crosslinked 
scaffolds and study their response to pH variations. The scaffolds were prepared in sample 
tubes with an inner diameter of 1.2 cm and 3 cm height using a casting solution with 3% 
(w/w) concentration and a freezing temperature of -50ºC. The prepared scaffolds were treated 
using CO2-assisted crosslinking process with different glutaraldehyde concentrations and 
different operation times, as previously described in Table 2.2. The effect of pH variations in 
swelling has been studied for chitosan and PVA blended hydrogels27 and similar results were 
obtained for the scaffolds in this work. In literature it is said that when chitosan hydrogels are 
placed in a buffer solution with a pH below its pKa (<6.3) there will be an ionization of 
primary amine groups in chitosan. The –NH2 groups of chitosan are positively charged          
(–NH3+) and this attracts and creates a higher concentration of counterions (Ac-) inside the 
hydrogel
 
and results in a new osmotic pressure inside and outside of the hydrogel. These 
positive charges also provide electrostatic repulsion forces, which contributes to the 
expansion of the hydrogel network. For a swelling medium with pH values higher than pKa of 
chitosan, the originally ionized groups in the gel matrix gradually lose their charges and, 
therefore, lose their attraction for couterions, eliminating the osmotic pressure difference, and 
the gel matrix contracts27. 
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Figure 2.9 – 3D-scaffolds prepared with 3% (w/w) of polymer in the casting solution: (a) picture of 
chitosan scaffold frozen at -20ºC (100CHT_3% -20ºC); (b) and (c) SEM images of chitosan scaffold 
frozen at -50ºC (100CHT_3% -50ºC) from two different regions; and SEM images of blended 
scaffolds frozen at -20ºC with: (d) 90% chitosan (90CHT_3% -20ºC), (e) 75% chitosan (75CHT_3% -
20ºC)  and (f) 50% chitosan (50CHT_3% -20ºC). 
(a) 
(b) (c) 
(d) (e) 
(f) 
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The results of the dynamic swelling tests in chitosan scaffolds are presented in Figure 2.10. 
The scaffolds that were crosslinked with 50% glutaraldehyde during 1 hour and during 10 
minutes (50%GTA_1H and 50%GTA_10min, respectively) presented low variations in 
swelling degree for different pH values. The swelling values for 50%GTA_1H were between 
1700% (pH 7) and 2000% (pH 5). The 3D-scaffolds treated with 0.1% of glutaraldehyde 
during 10 minutes (0.1%GTA_10min) began to dissolve, losing their weight along time. So, 
in the first 48 hours they showed a high swelling capacity, reaching 6848% at pH 5, but after 
96 hours the swelling value decreased to 4000% (pH 5), as a result of the scaffold dissolution. 
1%GTA_10min scaffold exhibited the expected swelling results, as the crosslinking treatment 
was enough to stabilize the structure but did not disable the scaffolds response to pH 
variations. The swelling values were around 1400%-1600% for pH 7 and 4100%-4500% for 
pH 5. 
The glutaraldehyde crosslinking treatment was used to enhance the biostability and the 
mechanical properties of the scaffolds, but a high concentration of the crosslinker will 
consume all the amino groups of chitosan in the crosslinking reaction, limiting the scaffolds 
response to pH stimulus. In the other hand, a low concentration of glutaraldehyde will be 
inefficient and the scaffolds will dissolve in solution, as it was verified for 0.1%GTA_10min. 
The crosslinking time also influenced the results and the scaffolds that were crosslinked for 1 
hour revealed to be the less sensitive to pH variations. Even so, 10 minutes appear to be 
enough time to uniformly crosslink the scaffolds. 
These swelling tests were initially performed in chitosan scaffolds that were freeze-dried at 
-50ºC. Morphological tests that were subsequently carried out have shown that a freezing 
temperature of -20ºC allows the formation of scaffolds with larger pores, as described in this 
work. For this reason, the next swelling tests were performed in scaffolds frozen at -20ºC. 
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Figure 2.10 – Dynamic swelling of 3D-scaffolds with 3% (w/w) of chitosan, frozen at -50ºC, 
crosslinked with different glutaraldehyde concentrations and using different operation times. 
 
The necessity to increase the scaffolds diameter for use in cell tests (sample tube with an 
inner diameter of 1.8 cm and 4 cm height) required an optimization in the crosslinking 
process. The optimal concentration of glutaraldehyde was determined in previous swelling 
tests as being 1% (v/v) but it was necessary to determine the appropriate operation time for 
these scaffolds. So, scaffolds crosslinking process was studied for 10 minutes and 30 minutes. 
The scaffolds crosslinked during 10 minutes (1%GTA_10min(2)) shown a great loss of mass 
after two days in PBS solution, while the 30 minutes crosslinked structures (1%GTA_30min) 
did not show significant differences. Therefore the following swelling tests were performed 
using the scaffolds crosslinked with 1% (v/v) of glutaraldehyde during 30 minutes. 
Figure 2.11 presents the results for the water uptake measurements on blended scaffolds. 
The swelling values obtained for 100CHT were the highest, around 2700%-2900% at pH 5, 
and decreased with the increase of PVA ratio. It was observed that 100CHT kept the 
appearance during swelling tests, while blended scaffolds lost some weight, mainly 50CHT. 
These results indicate that the crosslinking process was less efficient for scaffolds with PVA 
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content and, by the fact that PVA is a highly water soluble polymer, causes faster weight 
losses of these scaffolds. Even so, only 50CHT presents significant weight losses affecting the 
swelling results. Gunasekaran et al.27 studied the effect of the PVA content on the dynamic 
swelling of chitosan and PVA blended hydrogels. It was described that the PVA content 
shows no effect on the swelling values, because PVA does not have any ionisable groups in 
its molecular structure at any buffer pH value. This fact explains the decrease in swelling ratio 
as the PVA content of scaffolds increases, given that only chitosan is affected by the pH 
variations. 
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Figure 2.11 – Dynamic swelling of 3D-scaffolds prepared with 3% (w/w) of polymer 
(chitosan+PVA), frozen at -20ºC, crosslinked with 1% (v/v) of glutaraldehyde during 30 minutes and 
using different PVA ratios. 
3.3. In vitro biodegradation studies 
In vitro degradation tests were performed using lysozyme, an enzyme present in the human 
body and produced by macrophages during wound healing. Lysozyme degrades chitosan and 
permits the resorption of the scaffold, which is incorporated into the extracellular matrix for 
the rebuilding of physiological normal tissues26. Samples of each membrane and scaffold 
were soaked in PBS solution containing lysozyme and their remaining weight was measured 
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along time to determine the degradation of these structures. Additionally, other samples were 
soaked in PBS solution but without the addition of the enzyme, to distinguish the degradation 
kynetics with and without the presence of lysozyme. 
Figure 2.12 (a) shows that in PBS solution the remaining weight decreased mainly in the 
first week and depended on the PVA content. This fact implies that some of the PVA content 
dissolves in solution. In PBS solution with lysozyme, degradation occurs along the time, even 
after the first week, mainly for 100CHT and 75CHT, where the membranes degradation can 
be clearly observed by the reduction of weight (Figure 2.12 (b)). Comparing the two graphs, 
all the membranes placed in PBS solution with lysozyme presented a lower percentage of 
remaining weight after 30 days of degradation in comparison with membranes in PBS 
solution without lysozyme. The great reduction of membranes weight in the first week 
occurred because the pores allow the diffusion of the lysozyme into the matrix and, after some 
days of degradation, the pores collapse and less area is exposed to enzyme degradation. 
90CHT membranes presented a low degradation rate even after 30 days in PBS solution with 
lysozyme as observed in Figure 2.12 (b), but the SEM images in Figure 2.13 show that the 
degradation occurred and there was a collapse of the porous structure. For 100EVAP the 
remaining weight after 3 days in PBS solution was around 20% and in the presence of 
lysozyme only 2%, while the membranes prepared using CO2-assisted phase inversion 
method permitted the preparation of devices that kept more than 70% of their initial weight 
after 30 days of degradation. Normally, post-treatment processes are used to prevent 
structures dissolution what may carry some disadvantages. In this case, the use of 
supercritical technology allows the preparation of ready to use membranes without the 
necessity of any further treatments. 
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Figure 2.12 – Degradation curves of membranes in (a) PBS solution and (b) PBS solution containing 
lysozyme. 
 
(a) 
(b) 
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Figure 2.13 – SEM images of 90CHT membranes after 30 days in PBS solution containing lysozyme: 
(a) cross section (300x) and (b) surface top view (1000x). 
 
The degradation tests performed in crosslinked scaffolds 1%GTA_30min (crosslinking 
procedure during 30 minutes using glutaraldehyde with 1% (v/v)) revealed similar results as 
for membranes: PVA content of the scaffolds affected their degradation rate. In Figure 2.14 
(a) it is possible to note the same initial decrease of scaffolds weight as happened for 
membranes, which is probably due to the PVA dissolution in aqueous medium. In the 
presence of lysozyme as shown in Figure 2.14 (b) the degradation of the scaffolds occurs 
along the time and after 30 days the remaining weight is much lower than for the scaffolds 
placed in PBS solution without the enzyme. For example, after 30 days of degradation, 
50CHT placed in PBS solution presented 67% of remaining weight, while in PBS solution 
with lysozyme the corresponding value was 31%. Scaffolds are very porous structures what 
allows the diffusion of lysozyme into the matrices and their higher degradation when 
compared with membranes and leading to a decrease of the remaining weight along time. 
SEM images in Figure 2.15 presents the 100CHT scaffold after 65 days in PBS solution 
containing lysozyme and confirms the degradation results. 
 
 
(b) (a) 
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Figure 2.14 – Degradation curves of 3D-scaffolds prepared with 3% (w/w) of polymer 
(chitosan+PVA), frozen at -20ºC, crosslinked with 1% (v/v) of glutaraldehyde during 30min and using 
different PVA ratios in (a) PBS solution and (b) PBS solution containing lysozyme 
 
(a) 
(b) 
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Figure 2.15 – SEM images of 3D-scaffold prepared with 3% (w/w) of chitosan, frozen at -20ºC and 
crosslinked with 1% (v/v) of glutaraldehyde during 30min after 65 days in PBS solution containing 
lysozyme in different regions and using different magnifications (a) 800x and (b) 400x. 
 
3.4. Cytotoxicity assay 
The cytotoxicity tests evaluate the cell responses when interacting with the materials, which 
is an essential aspect in tissue engineering and regenerative medicine. Membranes with 
different compositions and scaffolds with different crosslinking concentrations and operation 
time were tested. 
Figure 2.16 presents images of L929 fibroblast cells cultured in membranes and in 
polystyrene (control) after 3 days in culture. It is possible to observe that cells cultured on 
100CHT presented their characteristic fibroblastic morphology (spindle shaped), while the 
cells on 50CHT presented a spherical morphology and no cell-cell contact. Table 2.9 
summarizes the response of L929 fibroblast cells cultured in the membranes, according to the 
images in Figure 2.16 and presenting the cell attachment, morphology, proliferation and cell-
cell contact results. 
(a) (b) 
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Figure 2.16 – Representative images of L929 fibroblast cells cultured in (a) 100CHT, (b) 75CHT, (c) 
50CHT and (d) polystyrene control after 3 days in culture, presenting their characteristic morphology. 
 
Table 2.9 – Response of L929 fibroblast cells cultured in the membranes 
 100CHT 75CHT 50CHT 
Cell Attachment +++ +++ +/- 
Cell Morphology +++ ++ +/- 
Cell-Cell Contact +++ + - 
Cell Proliferation +++ ++ +/- 
Cell Penetration N/A N/A N/A 
 
(d) 
(b) 
(c) 
(a) 
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Figure 2.17 presents the metabolic activity of the L929 cells (normalized to control) after 48 
hours of culture with medium extracts of the different membranes. No cytotoxic effect was 
observed for any of the membranes prepared, when compared to commonly used tissue 
culture grade polystyrene (negative control). The 90CHT membranes were not tested, but 
none of the other membranes that contain higher concentrations of PVA in their composition 
presented cytotoxicity. So, we may predict that these membranes will not present cytotoxic 
effects. In addition, the obtained results are in agreement with previously reported data 
attesting the non cytotoxicity of PVA/chitosan blended materials, containing 40% of chitosan 
and 60% of PVA in their composition28.  
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Figure 2.17 – Cytotoxicity tests of the membranes following the ISO standards for biomaterials. 
Negative control: tissue culture plate control (polystyrene); Positive control: 0.01 M phenol. 
 
The chitosan scaffolds that were submitted to a scCO2-assisted crosslinking treatment were 
tested for cytotoxicity using the direct method. The effects of the glutaraldehyde 
concentrations and the operation time in the toxicity were evaluated. 
Figure 2.18 presents representative images of L929 fibroblast cells cultured in the scaffolds 
and in polystyrene (control) after 3 days in culture. To complete this information, Table 2.10 
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summarizes the response of L929 fibroblast cells cultured in the scaffolds, presenting the cells 
attachment, proliferation and penetration. The results for scaffolds with a high concentration 
of glutaraldehyde and 1 hour of crosslinking treatment (50%GTA_1H) revealed that the cell 
response was affected (in the perifery some cell death was found), while the other scaffolds 
presented positive results with no visible cytotoxic effect on cells. The most positive results 
were observed for 1%GTA_10min, with a good cell attachment, proliferation and penetration, 
confirmed by the images, where it is possible to observe the presence of cells in different 
places inside the scaffold. These results are in agreement with the data reported by Chen et 
al.14 where the use of scCO2 is able to remove the entire remaining glutaraldehyde using a 
dynamic process, because of the high solubility of glutaraldehyde in scCO2. 
Therefore, the non-cytotoxicity of the membranes and scaffolds enables their potential use 
as scaffolds to sustain human stem cell adhesion and proliferation in vitro. 
 
Table 2.10 – Response of L929 fibroblast cells cultured in the 3D-scaffolds 
 0.1%GTA_10min 1%GTA_10min 50%GTA_10min 50%GTA_1H 
Cell 
Attachment 
++ ++ + +/- 
Cell 
Morphology 
N/A N/A N/A N/A 
Cell-Cell 
Contact 
N/A N/A N/A N/A 
Cell 
Proliferation 
+ ++ + +/- 
Cell 
Penetration 
+ ++ + +/- 
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Figure 2.18 – Representative images of L929 fibroblast cells cultured in (a) 0.1%GTA_10min, (b) 
1%GTA_10min, (c) 50%GTA_10min, (d) 50%GTA_1H and (e) polystyrene control after 3 days in 
culture. 
 
 
(c) (d) 
(e) 
(a) (b) 
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4. Conclusions 
This study has shown that it is possible to prepare stable and sterile chitosan and PVA 
blended membranes and 3D-scaffolds with potential use as tissue engineering scaffolds, 
taking advantage of the SCF technology. 
The versatility of scCO2-assisted phase inversion method allows the preparation of 
structures with different morphologies by varying the process conditions. In this work one of 
the main objectives was to study the influence of different chitosan/PVA ratios in membrane 
properties. The results showed that by adjusting the casting solution composition it was 
possible to modify the morphology, the hydrophilicity and the mechanical properties of the 
membranes. SEM and mercury porosimetry of these structures showed that the presence of 
PVA in the membranes composition causes a decrease in porosity values and an increase in 
pores interconnectivity. This dependence was also verified for the contact angle that 
decreased and the swelling degree that increased with higher PVA content. The mechanical 
properties of membranes were also modified by the existence of PVA in the membranes 
composition, increasing the elongation capacity of these structures and decreasing the 
supported break stresses. 
In 3D-scaffolds, not only the PVA ratio was evaluated, as well as the concentration of the 
casting solution and the freezing temperature used in the freeze-drying method. The scaffolds 
prepared with this technique are normally fragile and unstable in aqueous solution. To 
overcome this issue, it was applied a CO2-assisted crosslinking process with glutaraldehyde 
comprising the study of different glutaraldehyde concentrations and operation times. SEM 
and mercury porosimetry results showed that the casting solution concentrations that were 
studied had no influence in the 3D-scaffolds porosity neither in the interconnectivity between 
pores. In addition, the presence of PVA content in these matrices and the temperature used in 
the freeze-drying process affected their morphology. In swelling tests the 3D-scaffolds proved 
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to be pH-sensitive and the best response was obtained for scaffolds crosslinked with 1% (v/v) 
of glutaraldehyde during 10 minutes. 
Chitosan and PVA blended membranes and 3D-scaffolds were also tested for in vitro 
biodegradation and for cytotoxicity. The porous structures degraded along time in PBS 
solution containing lysozyme, with a higher degradation in the first days for matrices with 
more PVA content. In cytotoxicity tests, membranes were found to be non-cytotoxic, 
although a high content of PVA appeared to affect the cell attachment, morphology, 
proliferation and cell-cell contact. The results for crosslinked scaffolds showed no visible 
cytotoxic effects, except for high concentrations and high operation times where the cells 
response seemed to be affected. This reveals that the use of scCO2 in the crosslinking 
treatment presents an advantage in the preparation of scaffolds, removing the remaining 
glutaraldehyde after the crosslinking process. 
In conclusion, SCF technology allowed the preparation of sterile and ready-to-use devices, 
biodegradable and non-cytotoxic, with potential applications in tissue engineering and 
regenerative medicine, for example to support human stem cells proliferation and 
differentiation in vitro under controlled culture conditions. 
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